{Reference Type}: Journal Article {Title}: Human papillomavirus in men. {Author}: Gamboa-Hoil SI; {Journal}: Rev Int Androl {Volume}: 21 {Issue}: 1 {Year}: Jan-Mar 2023 {Factor}: 0.66 {DOI}: 10.1016/j.androl.2021.09.001 {Abstract}: To describe the clinical behavior of human papillomavirus in men.
Current international literature was reviewed to describe the clinical behavior of human papillomavirus in men.
Internationally, the overall prevalence of HPV DNA is 50.8%, HPV considered high risk are 14 types. Prevalence of HPV DNA in invasive penile cancer ranges from 33.1% to 47%. HPV-16 has been the most frequent (68.3%), followed by HPV-6 (8.1%) and HPV-18 (6.9%). Positive HPV is described as an independent prognostic factor for cancer-specific survival.
It is not clear why HPV infection has a predilection in specific areas of the genital tract. However, it is important to note that there are factors that increase the risk of HPV infection.